$Feasibility and clinical value of TIPS combined with subsequent antitumor treatment in HCC patients with refractory ascites$

Feasibility and clinical value of TIPS combined with subsequent antitumor treatment in HCC patients with refractory ascites

Background: Currently, hepatocellular carcinoma (HCC) patients with refractory ascites (RA) have a very poor prognosis, and there are no effective treatments recommended by the guidelines. A treatment strategy that utilizes a transjugular intrahepatic portosystemic shunt (TIPS) combined with subsequ...

Full description

Bibliographic Details
Main Authors:	Huzheng Yan, Guobao Wang, Wenliang Zhu, Kai Feng, Wenke Zhu, Xuan Wu, Zhenkang Qiu, Guanyu Chen, Weiwei Jiang, Fujun Zhang, Fei Gao
Format:	Article
Language:	English
Published:	Elsevier 2020-12-01
Series:	Translational Oncology
Online Access:	http://www.sciencedirect.com/science/article/pii/S1936523320303569

Similar Items

TIPS improves outcomes in patients with HCC and symptomatic portal hypertension: a multi-institution experience
by: Huzheng Yan, et al.
Published: (2022-02-01)

Retrograde venous coil embolization prior to transarterial chemoembolization in hepatocellular carcinoma with arterio-hepatic venous shunts
by: Wenliang Zhu, et al.
Published: (2022-11-01)

The Role of TIPS in Patients with Refractory Ascites and Portal Vein Thrombosis
by: Paulina Chinchilla-López, et al.
Published: (2017-07-01)

The Impact of Renal Function on Hepatic Encephalopathy Following TIPS Placement for Refractory Ascites
by: Matthew Zhao, et al.
Published: (2023-08-01)

Management of refractory ascites
by: Florence Wong
Published: (2023-01-01)

Resection vs. ablation for lesions characterized as resectable-ablative within the colorectal liver oligometastases criteria: a propensity score matching from retrospective study
by: Ma Luo, et al.
Published: (2020-01-01)

Ascites: Tips on diagnosis and management
by: Al Mofleh Ibrahim, et al.
Published: (1996-01-01)

Small-diameter TIPS combined with splenic artery embolization in the management of refractory ascites in cirrhotic patients
by: Nathan E. Frenk, et al.
Published: (2021-03-01)

A case of refractory ascites
by: Loris Varvello, et al.
Published: (2015-10-01)

Feasibility of a fast-track randomized controlled trial of cell-free and concentrated ascites reinfusion therapy for patients with refractory malignant ascites
by: Naosuke Yokomichi, et al.
Published: (2022-02-01)

Clinical Features of Refractory Ascites in Outpatients
by: Wanda Regina Caly, et al.

Automated low-flow ascites pump for the treatment of cirrhotic patients with refractory ascites
by: Guido Stirnimann, et al.
Published: (2017-02-01)

Safety and feasibility of transjugular intrahepatic portosystemic shunt in elderly patients with liver cirrhosis and refractory ascites.
by: Lena Stockhoff, et al.
Published: (2020-01-01)

Role of saphenoperitoneal shunt in management of refractory ascites
by: Ibrahim SMA,, et al.
Published: (2011)

Transjugular Portosystemic Shunting in Refractory Cirrhotic Ascites
by: Yu. V. Khoronko, et al.
Published: (2021-04-01)

Refractory ascites—the contemporary view on pathogenesis and therapy
by: Beata Kasztelan-Szczerbinska, et al.
Published: (2019-10-01)

Management of refractory cirrhotic ascites: challenges and solutions
by: Fukui H, et al.
Published: (2018-07-01)

IMPACT OF REFRACTORY ASCITES ON THE SURVIVAL OF PATIENTS WITH CIRRHOSIS
by: P.L. Pérez-Santos, et al.
Published: (2022-01-01)

Reinfusion of ascites during hemodialysis as a treatment of massive refractory ascites and acute renal failure
by: Ta-Wei Hsu, et al.
Published: (2011-02-01)

Refractory ascites and graft dysfunction in early renal transplantation
by: Catarina Pereira Eusébio, et al.
Published: (2019-03-01)

Synergism of antitumor action of dioxadet and cisplatin in model of ascitic ovarian tumor
by: V. G. Bespalov, et al.
Published: (2016-02-01)

Transjugular intrahepatic portosystemic shunt for the treatment of medically refractory ascites
by: Ahmad Parvinian,, et al.
Published: (2014-01-01)

Extrahepatic portomesenteric obstruction resulting in splanchnic hypertension and refractory ascites
by: Hussam Hindi, DO, et al.
Published: (2023-03-01)

Refractory ascites after laparoscopic cholecystectomy: a case report
by: Xiaoyun Cheng, et al.
Published: (2022-08-01)

Plasma concentration and efficacy of tolvaptan in cirrhotic patients with refractory ascites
by: Eri Sagawa, et al.
Published: (2019-04-01)

Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC
by: Rohini Sharma, et al.
Published: (2022-07-01)

Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in refractory ascites: Post-marketing surveillance results.
by: Norio Hanafusa, et al.
Published: (2017-01-01)

The Feasibility of TACE Combined with TKIs Plus PD-1 Antibody for Advanced HCC
by: Sun T, et al.
Published: (2023-03-01)

Risks and benefits of TIPS in HCC and other liver malignancies: a literature review
by: Anna Fichtl, et al.
Published: (2023-11-01)

Clinical efficacy of CT-guided 125I brachytherapy in patients with local residual or recurrent hepatocellular carcinoma after thermal ablation
by: Wenliang Zhu, et al.
Published: (2022-12-01)

Phase I study of intraperitoneal bevacizumab for treating refractory malignant ascites
by: Furong Kou, et al.
Published: (2021-02-01)

Propranolol use in patients with cirrhosis and refractory ascites: A nationwide study
by: Yen-Chun Chen, et al.
Published: (2022-01-01)

Refractory congenital chylous ascites: Role of fibrin glue in its management
by: Rahul Saxena, et al.
Published: (2020-01-01)

Feasibility of externalized peritoneovenous shunt (EPVS) for malignant ascites
by: Sakamoto Noriaki, et al.
Published: (2011-07-01)

Antitumor Activity and Antioxidant Status of the Methanol Extract of Careya arborea Bark Against Dalton’s Lymphoma Ascites-Induced Ascitic and Solid Tumor in Mice
by: Senthilkumar Natesan, et al.
Published: (2007-01-01)

Host antitumor resistance improved by the macrophage polarization in a chimera model of patients with HCC
by: Akira Asai, et al.
Published: (2017-04-01)

Antitumor activity of silver nanoparticles in Dalton&rsquo;s lymphoma ascites tumor model
by: Muthu Irulappan Sriram, et al.
Published: (2010-09-01)

Comparison between the internal and external pressure filtration methods of cell-free and concentrated ascites reinfusion therapy to treat refractory cancerous ascites
by: Jin Iwasaki, et al.
Published: (2017-11-01)

Successful treatment of refractory ascites in a child with transjugular intrahepatic portosystemic shunt
by: Lee, W.S., et al.
Published: (2001)

Intranodal lymphangiography under microsurgery for refractory lymphatic ascites after pelvic lymphadenectomy
by: Shota Higami, et al.
Published: (2024-04-01)